# Cardiovascular-kidney-metabolic (CKM) health Care topic · id `cardio:cardiovascular-kidney-metabolic-health` · Cardiovascular Atlas · release `5dcd9b263fe17744` (public) > General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations. Also called: Cardiovascular-kidney-metabolic syndrome Browse, organ or system: Heart; Kidneys; Metabolism Browse, condition area: Heart failure; Diabetes and metabolic disease; Kidney connections ## In plain language Cardiovascular-kidney-metabolic health is the way the American Heart Association's 2023 presidential advisory describes how metabolic risk factors, chronic kidney disease and the heart and blood vessels affect one another. The advisory says poor health in this area leads to many cardiovascular events and deaths, and that a growing number of treatments help metabolic risk factors, the kidneys or both while also protecting the heart. It calls for a clearer definition, a staging approach that supports prevention, prediction tools and care that joins up across specialties. ## Technical summary Scope page for the advisory in Circulation 2023;148(20):1606-1635, doi 10.1161/CIR.0000000000001184, PMID 37807924. Only the abstract was read, so the stages, the definitions and the prediction tools in the advisory body are not recorded. PubMed lists one correction (2024-03-26), whose text was not read. The advisory is guidance from the AHA, not a trial result. The plan asked for the staging framework; the abstract only says that a staging approach is needed. ## Claims, with the population each applies to ## Context: People with or at risk of cardiovascular-kidney-metabolic syndrome (AHA 2023 presidential advisory) Recipient: Recipient not specified; Population: People with, or at risk of, cardiovascular-kidney-metabolic syndrome. The abstract speaks of the population in general, of poor health being most common where social determinants of health are adverse, and of staging that supports prevention across the life course. It gives no age limits.; Care setting: Not stated in the abstract. The abstract calls for care models that join up several specialties.; Geography: Not stated in the abstract (American Heart Association advisory; jurisdiction not verified); Life stage: Across the life course, as the abstract words the aim of staging; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (guideline context) ### The abstract of the American Heart Association 2023 presidential advisory describes cardiovascular-kidney-metabolic health as the way metabolic risk factors, chronic kidney disease and the heart and vessels act on one another. It says poor health in this area has multisystem consequences, the most significant being a high rate of cardiovascular events and cardiovascular death, and that more treatment options now help metabolic risk factors, kidney function or both while also protecting the heart. It calls for a clearer definition of the syndrome, a staging approach that supports prevention across the life course, prediction algorithms and harmonized prevention and management strategies. - Category: Description - Evidence stage: Guidance - Certainty: Certainty not assessed - Applies to: Recipient: Recipient not specified; Population: People with, or at risk of, cardiovascular-kidney-metabolic syndrome. The abstract speaks of the population in general, of poor health being most common where social determinants of health are adverse, and of staging that supports prevention across the life course. It gives no age limits.; Care setting: Not stated in the abstract. The abstract calls for care models that join up several specialties.; Geography: Not stated in the abstract (American Heart Association advisory; jurisdiction not verified); Life stage: Across the life course, as the abstract words the aim of staging; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (guideline context) - Limitations: Only the abstract and the bibliographic record were read. The stages, the definitions and the prediction tools in the advisory body are not recorded. An advisory is guidance from the AHA, not a trial result. PubMed lists one correction (2024-03-26); its text was not read, so it is not known whether it changes anything stated here. - Last checked: 2026-10-15 - Source problem: a cited source is corrected. Check the sources before relying on this claim. - Sources: 1. Supports: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association (Publication, edition Published in Circulation 148(20):1606-1635 (issue date 2023-11-14; electronic publication 2023-10-09). PubMed abstract and bibliographic data only. PubMed lists no PMC copy. The advisory text was not read. PubMed lists 1 correction to the advisory; their text was not read. The publisher field is the journal title as PubMed gives it.) Locator: Abstract, sentences 1 and 2. Retrieved 2026-10-15T13:49:04Z. Source state: Corrected. Snapshot hash: 66acc9065fe752997fbf67c9f761343e5bc91d2c47d45117347f56d8ef46fb39. How it applies: The definition and the consequences. 2. Supports: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association (Publication, edition Published in Circulation 148(20):1606-1635 (issue date 2023-11-14; electronic publication 2023-10-09). PubMed abstract and bibliographic data only. PubMed lists no PMC copy. The advisory text was not read. PubMed lists 1 correction to the advisory; their text was not read. The publisher field is the journal title as PubMed gives it.) Locator: Abstract, sentence 4. Retrieved 2026-10-15T13:49:04Z. Source state: Corrected. Snapshot hash: 66acc9065fe752997fbf67c9f761343e5bc91d2c47d45117347f56d8ef46fb39. How it applies: More treatment options help risk factors, kidney function or both, with cardioprotective effects. 3. Supports: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association (Publication, edition Published in Circulation 148(20):1606-1635 (issue date 2023-11-14; electronic publication 2023-10-09). PubMed abstract and bibliographic data only. PubMed lists no PMC copy. The advisory text was not read. PubMed lists 1 correction to the advisory; their text was not read. The publisher field is the journal title as PubMed gives it.) Locator: Abstract, sentence 5. Retrieved 2026-10-15T13:49:04Z. Source state: Corrected. Snapshot hash: 66acc9065fe752997fbf67c9f761343e5bc91d2c47d45117347f56d8ef46fb39. How it applies: The four needs the advisory names. 4. Supports: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association (Publication, edition Published in Circulation 148(20):1606-1635 (issue date 2023-11-14; electronic publication 2023-10-09). PubMed abstract and bibliographic data only. PubMed lists no PMC copy. The advisory text was not read. PubMed lists 1 correction to the advisory; their text was not read. The publisher field is the journal title as PubMed gives it.) Locator: Abstract, sentence 7. Retrieved 2026-10-15T13:49:04Z. Source state: Corrected. Snapshot hash: 66acc9065fe752997fbf67c9f761343e5bc91d2c47d45117347f56d8ef46fb39. How it applies: What the advisory provides guidance on. 5. Background: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association (Publication, edition Published in Circulation 148(20):1606-1635 (issue date 2023-11-14; electronic publication 2023-10-09). PubMed abstract and bibliographic data only. PubMed lists no PMC copy. The advisory text was not read. PubMed lists 1 correction to the advisory; their text was not read. The publisher field is the journal title as PubMed gives it.) Locator: CommentsCorrectionsList, ErratumIn entry. Retrieved 2026-10-15T13:49:04Z. Source state: Corrected. Snapshot hash: 66acc9065fe752997fbf67c9f761343e5bc91d2c47d45117347f56d8ef46fb39. How it applies: Shows that a correction exists. What it changes is unknown. ## Connected pages - Kidney disease is one of the three parts of the framework: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`) - Related metabolic condition: Type 2 diabetes (`cardio:type-2-diabetes`) - AHA presidential advisory: American Heart Association (`core:aha`) - Files under this front: Kidney and metabolic care (`cardio:front-kidney-and-metabolic-care`) ## Provenance Content hash: a08f5811e02051f1591c4a04954084d20f45667fce9c22c7e2fdfda2c418d34f Last substantive edit: 2026-10-15 Evidence last checked: 2026-10-15